SIREN : 479977183
LABORATOIRE OCELLUS is a French company founded 21 years ago, specialized in the sector Commerces de détail d'optique. Based in PARIS (75001), this company of category PME shows in 2024 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 080 897 € | 1 294 806 € | 1 305 066 € | 653 717 € | 593 384 € | 457 063 € | N/C | 3 450 € |
| Net income | 17 125 € | 59 767 € | 56 651 € | 96 659 € | 41 931 € | 46 495 € | 54 085 € | 28 650 € |
| EBITDA | 59 561 € | 90 032 € | 71 049 € | 131 251 € | 50 230 € | 23 955 € | -5 831 € | -3 348 € |
| Net margin | 1.6% | 4.6% | 4.3% | 14.8% | 7.1% | 10.2% | N/C | 830.4% |
In 2024, LABORATOIRE OCELLUS achieves revenue of 1.1 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +105.1%. Significant drop of -17% vs 2022. After deducting consumption (209 k€), gross margin stands at 872 k€, i.e. a rate of 81%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 60 k€, representing 5.5% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 17 k€, i.e. 1.6% of revenue. This profit can be retained or distributed to shareholders.
1 080 897 €
871 890 €
59 561 €
6 776 €
17 125 €
5.4%
The debt ratio (= Financial debt / Equity x 100) stands at 95%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.2 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 5.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
94.896%
26.773%
5.369%
6.167
32.2%
In 2024, the debt ratio of LABORATOIRE OCELLUS (94.90) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of LABORATOIRE OCELLUS (26.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of LABORATOIRE OCELLUS (6.17) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 152.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 18.4x. Operating income very largely covers interest expenses: high safety margin.
152.158
18.445
In 2024, the liquidity ratio of LABORATOIRE OCELLUS (152.16) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of LABORATOIRE OCELLUS (18.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 163 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 256 days. Excellent situation: suppliers finance 93 days of the operating cycle (retail model). Inventory turnover is 73 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 288 days of revenue, i.e. 865 k€ to permanently finance. Over 2016-2024, WCR increased by +58596%, requiring additional financing.
864 599 €
163 j
256 j
73 j
288 j
Based on 117 transactions of similar company sales in 2024, the value of LABORATOIRE OCELLUS is estimated at 298 314 € (range 182 935€ - 504 186€). With an EBITDA of 59 561€, the sector multiple of 4.0x is applied. The price/revenue ratio is 0.53x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 117 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LABORATOIRE OCELLUS with other companies in the same sector:
Voir toutes les statistiques du secteur Commerces de détail d'optique
The revenue of LABORATOIRE OCELLUS in 2024 is 1.1 M€.
Yes, LABORATOIRE OCELLUS generated a net profit of 17 k€ in 2024.
The headquarters of LABORATOIRE OCELLUS is located in PARIS (75001), in the department Paris.
The tax return of LABORATOIRE OCELLUS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LABORATOIRE OCELLUS operates in the sector Commerces de détail d'optique (NAF code 47.78A). See the 'Sector positioning' section above to compare the company with its competitors.